TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of changes from baseline in imaging diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Oswestry Disability Index (ODI) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post-operative infectious complications
Endpoint domain: Adverse events/effects
Primary endpoint: Complication risks
Endpoint domain: Adverse events/effects
Primary endpoint: Change in quantify urine loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mean vertical displacement of the anterior wall of the vagina
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of first postoperative exhaust
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of streamlines connecting between intracranial stimulation volume and recording volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Evoked potentials arising from stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with grade 1-4 cytokine release syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with allo-immunisation
Endpoint domain: Adverse events/effects
Primary endpoint: GLUT4 protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TB1CD4 protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Endurance Shuttle Walk Test (ESWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced expiratory volume in 1 second/ forced vital capacity ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of pain relief
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Regain Life Independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Responder rate with NanaBis™ spray
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression and epigenetic signatures in TNBC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal physical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal laboratory examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MDS-UPDRS Part III (motor score) in OFF state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: sensitivity and specificity of BRCA1/2 testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of patients correctly classified for BRCA1 and 2 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral blood velocity measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: End-tidal carbon dioxide measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The positive rate of intestinal diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Minimal Clinically Important Difference (MCID)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Short Form Health Survey-12 General Quality of life questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: humoral immune response against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Maternal Participants Reporting Any Solicited Administration Site Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Maternal Participants Reporting Any Serious Adverse Events (SAEs) From Day 1 up to 42 Days Post-delivery
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Live Births With no Congenital Anomalies, Live Births With Minor Congenital Anomaly(Ies) and Live Births With at Least 1 Major Congenital Anomaly
Endpoint domain: Adverse events/effects
Primary endpoint: Number of psychiatric emergencies
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: N terminal pro-B-type natriuretic peptide (NT-proBNP) decline level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac Troponin T (cTnT) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neck flexor-extensor muscle endurance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant Uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant Feedback About Experience of the Programme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Opioid Prescription at Discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: need of supplemental dosage of Ibuprofen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of Korean version of the Fugl-Meyer Assessment Scale (K-FMA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sagittal spinal curvature in relaxed standing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sagittal spinal curvature in active alignment in standing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sagittal spinal curvature in relaxed sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Internal Jugular Vein (IJV) area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: IJV pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Intraocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of graft uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NIMH Symptom Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effect of treatment on VVA symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assess the effect of treatment on the general quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The effect of the treatment on Sexual Function
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Improvement in ADRD patient's condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevention of decline in ADRD patient's condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Geriatric Depression Scale (GDS) raw score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in NIH Toolbox-Cognition Battery (NIHTB-CB) Fluid Composite
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Amount of maxillary canine retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Visual Analog Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 18F-flutemetamol cardiac PET imaging markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peripheral inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: White matter microstructure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in skin pigmentation in the undereye area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Evaluation of rotator cuff vascularity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guillain-Barre Syndrome Disability Scale (GBS-DS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: First-attempt success rate of RSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maternal insulin requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maternal Blood glucose readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SAE frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Bilateral Internal jugular vein blood flow characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Bilateral Internal jugular vein pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Bilateral Internal jugular vein area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Amplitude of TSCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort and fit
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes of peak expiratory flow rate (PEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Edmonton Symptom Assessment Scale (ESAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Specific absorbed dose to the target lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in heart rate as beats per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Antidepressive Effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of Intracerebral Hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in IBM Functional Rating Scale (IBM-FRS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of completed self-measurement of Blood Pressure at home
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maternal Weight gain during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence - Mid-Ohio Farmacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence - Health Impact Ohio
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence - Behavioral Nutritional Counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Motivation Scale Related to Instructional Material
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hand Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Finger Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic outcomes of patients with breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Patients With Treatment-emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Patients With Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Patients With Adverse Events of Specific Interest
Endpoint domain: Adverse events/effects
Primary endpoint: Half-life of Sotrovimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boston Carpal Tunnel Questionnaire - Symptom Severity Scale (BCTQ-SSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximal increase in copeptin levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reflectivity measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Segmentation measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical bone height gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Bone density around implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Informed vaccination intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respiratory Illness Burden Index (RIBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adult word count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported parental beliefs about the value of IDS (Index)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported parental IDS behavior (Index)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Immediate Total Volatile Sulphur Compounds (T-VSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of responders with HbA1c reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction or elimination of bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Willingness to accept kidney transplantation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breast Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of participants who completed the three-month outpatient treatment program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Pittsburgh sleep quality index (PSQI) scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Perioperative infections
Endpoint domain: Adverse events/effects
Primary endpoint: Long-term stricture resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of enrolled participants retained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of complications or adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of pain following placebo injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Within-subjects variability of day-to-day clinical pain reports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postimplantation syndrome incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in behaviors related to assessing and assisting parents with mental health challenges
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of parents declining to complete the screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diagnostic efficacy of plasma exo-RNA panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-operative vascular clamping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Parent Fidelity of Implementation of Pivotal Response Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diaphragmatic excursion assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Chest wall expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Identification of peptide targets and associated TCRs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Health-Promoting Lifestyle Profile II score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of Tele-BE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of Tele-BE
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Usability of Tele-BE
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinician Fidelity to CBT Structural Components
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Concentrations of classical monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentrations of intermediate monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentrations of non-classical monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Disease control rate at 16 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Similarity of biological information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac Troponin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum Core Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep Measurement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Intra-abdominal pressure (IAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reflective marker displacement (RMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant change in vital signs, ECG, safety laboratory test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sun protection index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of 99mTCc-ECDG in evaluating Coronary Artery Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tympanic temperature measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in urine protein to creatinine ratio (UPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Occurrence of intensive care unit-acquired weakness (ICUAW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in coronary plaque characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of difficult intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of difficult bag and mask ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tooth Shade evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oldenburg Sentence Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causal genetic diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNVs reclassified as pathogenic/probably pathogenic or benign/probably benign
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Molecular diagnosis identified by sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with reverse remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of harvested CD34+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Kappe Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HbA1c(%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Sudapyridine (WX-081)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Plasma Concentration (Tmax) of Sudapyridine (WX-081)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve (AUC0-t and AUC0-∞) of Sudapyridine (WX-081)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WOMAC pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Number, Frequency and Severity of Product Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of Ulcer Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of Ulcer Width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of Ulcer Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of volume of the ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of serum IL-6 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Perception score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence and distribution of biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between eye-tracking biomarker score and autism diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes